LMAT - CIK 0001158895
LEMAITRE VASCULAR INC (LMAT) reported revenue of $249.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $249.60M | +13.5% |
| FY 2024 | $219.86M | +13.6% |
| FY 2023 | $193.48M | +19.7% |
| FY 2022 | $161.65M | +4.7% |
| FY 2021 | $154.42M | +19.4% |
| FY 2020 | $129.37M | +10.4% |
| FY 2019 | $117.23M | +11.0% |
| FY 2018 | $105.57M | +4.7% |
| FY 2017 |
LEMAITRE VASCULAR INC (LMAT) reported revenue of $249.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, LEMAITRE VASCULAR INC's revenue grew from $57.69M to $249.60M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $100.87M |
| +13.1% |
| FY 2016 | $89.15M | +13.8% |
| FY 2015 | $78.35M | +10.2% |
| FY 2014 | $71.10M | +10.1% |
| FY 2013 | $64.55M | +13.8% |
| FY 2012 | $56.73M | -1.6% |
| FY 2011 | $57.69M | - |